Abigail Brooks

5 days ago | consultantlive.com | Abigail Brooks

New research is shedding light on the potential utility of mobile apps for improving medication adherence among patients with chronic kidney disease (CKD).1The systematic review included 9 studies comprising 1023 participants at various stages of CKD management, including hemodialysis, peritoneal dialysis, and post-kidney transplant.

1 week ago | consultantlive.com | Abigail Brooks

New research is shedding light on sex-based differences in binge and heavy drinking patterns among US adults, highlighting notable fluctuations in drinking patterns relative to historical trends.1 Leveraging National Survey on Drug Use and Health (NSDUH) data from 2017 to 2019 and 2021 to 2023, the study found past-month binge drinking rates were greater among young adult females than males during the 2021 to 2023 period, reversing 2017 to 2019 patterns, whereas males in other age groups...

1 week ago | consultantlive.com | Abigail Brooks

The US Food and Drug Administration has approved a new tablet formulation of maralixibat (Livmarli) for the treatment of cholestatic pruritus in patients with Alagille syndrome (ALGS) and progressive familial intrahepatic cholestasis (PFIC).1According to an April 14, 2025, press release from Mirum Pharmaceuticals, maralixibat tablets are planned to be available in June through Mirum Access Plus.

1 week ago | consultantlive.com | Abigail Brooks

New research suggests switching to besifovir dipivoxil maleate (BSV) therapy may improve renal and bone health in patients with chronic hepatitis B virus (HBV) previously receiving long-term tenofovir disoproxil fumarate (TDF) treatment.1The randomized, open-label, active-controlled, non-inferiority phase 4 clinical trial found switching to a 48-week BSV therapy regimen after long-term TDF demonstrated noninferior antiviral efficacy compared to maintaining TDF.

2 weeks ago | consultantlive.com | Abigail Brooks

New research is shedding light on the potential utility of electronic health interventions for improving medication adherence and subsequent patient outcomes in kidney transplant recipients.1 Findings from the systematic review and meta-analysis of 8 randomized controlled trials (RCTs) of patients receiving immunosuppressive therapy following kidney transplantation suggest use of electronic health interventions, including mobile apps, electronic pillboxes, text and email reminders,...